Volume 24, Number 1—January 2018
Research Letter
Epidemiology of Cutaneous Leishmaniasis Outbreak, Waziristan, Pakistan
Table
Area |
No. tested |
CL-positive samples, no.* | CL prevalence, % | |||
---|---|---|---|---|---|---|
Microscopy |
PCR |
Microscopy |
PCR |
|||
North Waziristan | ||||||
Shewa | 966 | 29 | 35 | 3† | 3.62† | |
Spinwam | 530 | 17 | 21 | 3.2† | 3.96† | |
Mirali | 320 | 6 | 7 | 1.87 | 2.18 | |
Edaky | 463 | 9 | 11 | 1.94 | 2.37 | |
Darpakheil | 450 | 11 | 14 | 2.44 | 3.11† | |
Hasankheil | 373 | 9 | 11 | 2.41 | 2.94 | |
Dosali | 512 | 19 | 24 | 3.71† | 4.68† | |
Miranshah | 455 | 15 | 17 | 3.29† | 3.73† | |
Razmak | 367 | 14 | 16 | 3.81† | 4.35† | |
Subtotal |
4,436 |
129 |
156 |
2.91 |
3.51† |
|
South Waziristan | ||||||
Wanna | 412 | 14 | 28 | 3.39 | 6.79† | |
Shekai | 463 | 12 | 18 | 2.59 | 3.88† | |
Jandola | 516 | 10 | 10 | 1.93 | 1.93 | |
Sra Roha | 253 | 8 | 11 | 3.16† | 4.34† | |
Makeen | 169 | 4 | 9 | 2.36 | 5.32† | |
Janata | 448 | 6 | 11 | 1.33 | 2.45 | |
Sreykhoray | 195 | 6 | 12 | 3.07† | 6.15† | |
Kotkai | 755 | 12 | 18 | 1.58 | 2.38 | |
Subtotal |
3,112 |
72 |
117 |
2.3 |
3.75† |
|
Total |
7,548 |
201 |
273 |
2.66 |
3.61 |
|
*CL, cutaneous leishmaniasis. †Denotes statistically significant difference (p<0.05) analyzed by χ2 test. In South Waziristan, the highest prevalence rate (6.79% by PCR), was found in Wanna district; in North Waziristan, Dosali had the highest prevalence (4.68% by PCR). However, South Waziristan showed a higher prevalence rate, 3.75% (117/3,112), than North Waziristan’s 3.51% (156/4,436). |
Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.